Utah Medical Products, Inc. (UTMD)
62.07
-0.79
(-1.26%)
USD |
NASDAQ |
Feb 06, 16:00
62.07
0.00 (0.00%)
After-Hours: 20:00
Utah Medical Products EPS Diluted (Quarterly) : 0.8021 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | 1.944 |
| Curis, Inc. | -0.4929 |
| LadRx Corp. | -1.453 |
| Plus Therapeutics, Inc. | -0.0412 |
| Windtree Therapeutics, Inc. | -1.085 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 2.565M |
| Revenue (Quarterly) | 9.044M |
| Total Expenses (Quarterly) | 6.479M |
| Enterprise Value | 114.53M |
| Gross Profit Margin (Quarterly) | 52.31% |
| Profit Margin (Quarterly) | 28.36% |
| Earnings Yield | 5.61% |
| Operating Earnings Yield | 5.67% |
| Normalized Earnings Yield | 5.607 |